You are my Small-Animal Veterinary Medicine Professor, Clinical Mentor, and Case-Simulation Trainer. I am a practicing small-animal veterinarian (dogs and cats) and I want to learn veterinary medicine at an advanced, practical, clinic-ready level. Whenever I give you a disease/topic, teach me the topic from basics to advanced clinical management, as if you are training me to become a highly competent small-animal GP. TOPIC: CKD/AKI IN DOGS AND CATS] For every disease, follow this exact structure: 1. BASIC UNDERSTANDING * Definition * Species affected: dog/cat/both * Age/breed/sex predisposition * Epidemiology * Causes * Risk factors * Pathogenesis — explain step-by-step in simple language * Why the clinical signs occur 2. HISTORY TAKING Tell me exactly what history I should ask the owner: * Chief complaint * Duration and progression * Appetite * Water intake * Urination * Defecation * Vomiting/diarrhoea * Coughing/sneezing * Exercise tolerance * Vaccination/deworming * Diet * Medication history * Previous diseases * Trauma/toxin exposure * Travel/boarding/contact history * Tick/flea exposure * Reproductive history when relevant Give me a ready-to-use history-taking checklist for the clinic. 3. CLINICAL EXAMINATION Explain: * TPR * Mucous membranes * CRT * Hydration * Lymph nodes * Body condition * Pain assessment * Cardiovascular examination * Respiratory examination * Abdominal palpation * Neurological examination when relevant * Skin/eyes/ears/oral examination when relevant Tell me what abnormalities I should specifically look for and what each finding means. 4. DIFFERENTIAL DIAGNOSIS Give me: * Most important differentials * Common differentials * Life-threatening differentials * How to differentiate each condition clinically * Key distinguishing laboratory/imaging findings Create a comparison table whenever useful. 5. CBC INTERPRETATION Explain expected CBC findings: * Hb * PCV/HCT * RBC * MCV * MCH/MCHC * WBC * Neutrophils * Lymphocytes * Monocytes * Eosinophils * Platelets * Reticulocytes when relevant Explain: What changes → Why it changes → What it means clinically. Also explain important patterns such as: * Regenerative vs non-regenerative anaemia * Left shift * Toxic neutrophils * Neutrophilia/neutropenia * Lymphocytosis/lymphopenia * Thrombocytopenia/thrombocytosis 6. SERUM BIOCHEMISTRY Explain expected changes in: * ALT * AST * ALP * GGT * Bilirubin * Albumin * Globulin * Total protein * BUN * Creatinine * SDMA when relevant * Glucose * Cholesterol * Triglycerides * Calcium * Phosphorus * Sodium * Potassium * Chloride * Amylase/lipase * Spec cPL/fPL when relevant For every abnormal parameter explain: Increase/decrease → mechanism → clinical significance. 7. URINALYSIS Explain: * Urine specific gravity * pH * Protein * Glucose * Ketones * Blood * Bilirubin * Sediment * RBC * WBC * Casts * Crystals * Bacteria Explain how urinalysis helps confirm or rule out the disease. 8. DIAGNOSTIC PLAN Give me a practical diagnostic algorithm: History → Physical examination → Minimum database → Specific tests → Imaging → Confirmatory diagnosis Clearly separate: * Minimum database * Recommended tests * Gold-standard/confirmatory tests * Tests needed in severe cases/emergencies 9. IMAGING Explain when to use: * Radiography * Ultrasound * Echocardiography * CT * MRI For radiographs, explain what views to take and what findings I should look for. For ultrasound, explain the expected sonographic findings and important differentials. 10. DIAGNOSIS Explain: * Presumptive diagnosis * Definitive diagnosis * Diagnostic criteria * How to interpret conflicting test results * Common diagnostic mistakes 11. TREATMENT PROTOCOL Give me a practical veterinary treatment protocol. For every drug include: * Generic name * Drug class * Indication * Dose in mg/kg * Route * Frequency * Duration * Maximum dose if relevant * Mechanism of action * Important adverse effects * Contraindications * Major drug interactions * Monitoring requirements Separate treatment into: A. Mild cases B. Moderate cases C. Severe/critical cases D. Emergency/ICU management Do NOT simply list drugs. Explain why each drug is being used. 12. FLUID THERAPY Explain: * Whether fluids are indicated * Choice of fluid * Maintenance requirement * Deficit calculation * Ongoing losses * Shock resuscitation when applicable * Fluid rate * Bolus strategy * Monitoring * When to reduce/stop fluids * Signs of fluid overload Give formulas and worked examples for different body weights. 13. DOSE CALCULATIONS Show me how to calculate doses. Use examples for: * 2 kg cat * 5 kg cat * 10 kg dog * 20 kg dog * 30 kg dog Show: Dose (mg) = body weight (kg) × dose (mg/kg) Then convert the dose into mL when a concentration is provided. If concentration is not provided, ask me for the exact product concentration rather than guessing. 14. SUPPORTIVE CARE Explain: * Nutrition * Feeding strategy * Anti-emetics * Analgesia * Gastroprotection * Antibiotic indications * Vitamins/electrolytes when indicated * Oxygen therapy * Blood products * Nursing care * Temperature management Clearly distinguish evidence-based indications from treatments that are commonly used but may not be necessary. 15. ANTIBIOTIC STEWARDSHIP If antibiotics are relevant: * When antibiotics are actually indicated * First-line choices * Alternative choices * Culture/sensitivity indications * Empirical therapy * De-escalation/step-down therapy * Duration * Important resistance considerations Never recommend antibiotics merely because a disease is serious if there is no bacterial indication. 16. PROGNOSIS Explain: * Good prognostic indicators * Poor prognostic indicators * Survival considerations * Factors affecting outcome * When referral/ICU/surgery is indicated 17. MONITORING Give me a monitoring sheet: * TPR * BP * SpO₂ * ECG when relevant * Urine output * Hydration * Pain * Appetite * Weight * CBC * Biochemistry * Electrolytes * Disease-specific markers Tell me how frequently each should be monitored in mild, moderate and severe cases. 18. COMMON CLINICAL MISTAKES Tell me the most common mistakes veterinarians make while diagnosing and treating this disease. Also tell me: “What can I miss if I focus only on the obvious diagnosis?” 19. RED FLAGS Give me a clear list of signs requiring: * Immediate hospitalization * Emergency stabilization * ICU * Blood transfusion * Surgery * Specialist referral 20. CASE SIMULATION Create a realistic dog/cat case. Give me only: * Signalment * History * Clinical examination * CBC * Biochemistry * Urinalysis * Imaging findings Then ask me to: 1. Identify major problems 2. Give differential diagnoses 3. Interpret CBC 4. Interpret biochemistry 5. Choose further tests 6. Give diagnosis 7. Create treatment plan 8. Calculate drug doses 9. Create monitoring plan 10. Give prognosis Do NOT reveal the answer initially. After I answer, evaluate my clinical reasoning like a senior veterinary clinician and correct every mistake. 21. QUICK CLINICAL ALGORITHM At the end, give me a one-page practical algorithm: Presentation → History → Examination → Differentials → Tests → Diagnosis → Treatment → Monitoring → Discharge/Follow-up 22. MEMORY TOOL Finish with: * 10 key points to remember * 10 important drug facts * 10 diagnostic clues * 10 common mistakes * 10 high-yield MCQs * 5 clinical pearls IMPORTANT RULES 1. Teach me at small-animal clinical-practice level, not merely textbook level. 2. Use dogs and cats separately whenever their management differs. 3. Explain difficult concepts in simple English + Hindi-English mix when needed. 4. Always explain the reasoning behind diagnostic and treatment decisions. 5. Never invent drug concentrations, laboratory values, guidelines, or doses. 6. For drug dosing, clearly distinguish standard/reference dosing from case-specific prescribing. 7. Flag drugs that are contraindicated or potentially dangerous in cats. 8. Mention important renal/hepatic dose considerations. 9. Mention when a drug requires therapeutic drug monitoring. 10. For critical/emergency diseases, prioritize stabilization using ABC principles before definitive diagnosis. 11. If current guidelines or drug recommendations may have changed, verify them using reliable veterinary sources before answering. 12. Cite authoritative sources/guidelines when making important clinical recommendations. 13. If my question is ambiguous, ask for the minimum information needed rather than making unsafe assumptions. 14. Do not overwhelm me with unexplained jargon. Teach the underlying physiology and clinical reasoning. 15. Train me to think like a veterinarian, not memorize lists. Start with the topic I provide and teach it from BEGINNER → INTERMEDIATE → ADVANCED → CLINICAL CASE LEVEL.

Reading File
This is a broad renal-medicine module. To make it clinic-ready rather than a superficial list, we should take one focused block at a time.
  1. Renal foundations and classification
    • Renal physiology, azotaemia versus uraemia, prerenal/renal/postrenal causes
    • AKI versus CKD versus acute-on-chronic kidney disease
    • IRIS staging and substaging for dogs and cats
  2. AKI in dogs and cats
    • Triage, differentials, diagnostic work-up, fluid strategy, oliguria/anuria, toxin and infectious causes, ICU monitoring
  3. CKD in dogs and cats
    • Staging, proteinuria and hypertension, renal diet, phosphate control, nausea/appetite management, anaemia, follow-up planning
  4. Diagnostics and interpretation
    • CBC, biochemistry, SDMA, electrolytes, urinalysis, UPC, urine culture, blood pressure, radiography and ultrasound
    • Interpretation of difficult patterns, including dehydration masking CKD and AKI-on-CKD
  5. Therapeutics and calculations
    • Evidence-based drug choices, renal dose cautions, fluid calculations, nutrition, antiemetics, antihypertensives, antiproteinuric therapy, phosphate binders, potassium management and antibiotic stewardship
  6. Complications, referral decisions and case simulations
    • Hyperkalaemia, hypertension, pulmonary oedema, severe acidosis, oliguria/anuria, urolith obstruction, dialysis indications, prognosis, monitoring, and practical case reasoning
High-level overview: AKI is a sudden decline in renal function, often potentially reversible if perfusion is restored and the initiating cause is addressed early. The immediate priority is ABC stabilization, confirmation of urine flow, electrolyte and acid-base assessment, and avoiding both fluid under-resuscitation and iatrogenic fluid overload.
CKD is progressive, irreversible loss of functioning nephrons. Management aims to slow progression and preserve quality of life, especially with renal nutrition, control of phosphorus, proteinuria and hypertension, plus active treatment of nausea, dehydration, anaemia and electrolyte disturbances. Dogs and cats differ meaningfully, particularly in common causes, hypertension prevalence, potassium trends and drug tolerance.
Asking for Preferences

Which focused module should we cover first in the full clinical format you requested?

This is a broad renal-medicine module. To make it clinic-ready rather than a superficial list, we should take one focused block at a time.
  1. Renal foundations and classification
    • Renal physiology, azotaemia versus uraemia, prerenal/renal/postrenal causes
    • AKI versus CKD versus acute-on-chronic kidney disease
    • IRIS staging and substaging for dogs and cats
  2. AKI in dogs and cats
    • Triage, differentials, diagnostic work-up, fluid strategy, oliguria/anuria, toxin and infectious causes, ICU monitoring
  3. CKD in dogs and cats
    • Staging, proteinuria and hypertension, renal diet, phosphate control, nausea/appetite management, anaemia, follow-up planning
  4. Diagnostics and interpretation
    • CBC, biochemistry, SDMA, electrolytes, urinalysis, UPC, urine culture, blood pressure, radiography and ultrasound
    • Interpretation of difficult patterns, including dehydration masking CKD and AKI-on-CKD
  5. Therapeutics and calculations
    • Evidence-based drug choices, renal dose cautions, fluid calculations, nutrition, antiemetics, antihypertensives, antiproteinuric therapy, phosphate binders, potassium management and antibiotic stewardship
  6. Complications, referral decisions and case simulations
    • Hyperkalaemia, hypertension, pulmonary oedema, severe acidosis, oliguria/anuria, urolith obstruction, dialysis indications, prognosis, monitoring, and practical case reasoning
High-level overview: AKI is a sudden decline in renal function, often potentially reversible if perfusion is restored and the initiating cause is addressed early. The immediate priority is ABC stabilization, confirmation of urine flow, electrolyte and acid-base assessment, and avoiding both fluid under-resuscitation and iatrogenic fluid overload.
CKD is progressive, irreversible loss of functioning nephrons. Management aims to slow progression and preserve quality of life, especially with renal nutrition, control of phosphorus, proteinuria and hypertension, plus active treatment of nausea, dehydration, anaemia and electrolyte disturbances. Dogs and cats differ meaningfully, particularly in common causes, hypertension prevalence, potassium trends and drug tolerance.
Choose one module to start in the full clinic-ready format:
  1. AKI emergency care - triage, oliguria/anuria, hyperkalaemia, toxins, ICU fluids
  2. CKD practical management - IRIS staging, diet, proteinuria, hypertension, phosphate, anaemia
  3. Diagnostics interpretation - CBC, biochemistry, SDMA, urinalysis, UPC, BP, imaging
  4. Renal therapeutics - drugs, doses, fluid calculations, contraindications, monitoring
  5. Complications and case simulation - acute-on-chronic disease, obstruction, referral/dialysis, clinical case
Reply with the number or module name.

Start with a full AKI emergency-care module

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

acute kidney injury dogs cats

Searching the Web

IRIS acute kidney injury grading dogs cats guidelines fluid therapy 2024

Searching Images

dog acute kidney injury renal ultrasound enlarged hyperechoic kidneys

Finding Sources
Finding Sources
Searching PubMed

acute kidney injury dog cat management

Searching the Web

veterinary acute kidney injury dogs cats management oliguria anuria guidelines fluid therapy

Reading Web Page

https://todaysveterinarypractice.com/internal-medicine/a-gui…

Reading Article

PMID: 35379499

Searching PubMed

acute kidney injury cats dogs consensus guidelines

Searching Images

dog kidney ultrasound acute kidney injury nephromegaly hyperechoic renal cortex

Acute Kidney Injury in Dogs and Cats: Emergency-Care Module

Clinical aim: identify reversible prerenal and postrenal disease immediately, stabilize ABCs, stop ongoing renal injury, measure urine output accurately, correct life-threatening electrolyte and acid-base abnormalities, and avoid fluid overload.
AKI is not synonymous with azotaemia. A patient can have substantial acute renal tubular injury before creatinine rises. Serial trends and urine output matter. IRIS grades AKI I-V using creatinine plus clinical features and urine flow, but grading does not replace identifying the cause. See the current IRIS AKI framework and the 2024 IRIS dialysis guideline.

1. BASIC UNDERSTANDING

Definition

Acute kidney injury (AKI) is an abrupt decline in renal function causing decreased GFR, impaired tubular function, and variable oliguria, anuria, polyuria, azotaemia, electrolyte/acid-base derangements, and uraemic illness.
It may be:
  • Prerenal: reduced renal perfusion, kidneys initially structurally intact.
  • Intrinsic renal: direct nephron injury.
  • Postrenal: impaired urine outflow, urine leakage, or obstruction.
  • Acute-on-chronic kidney disease: an acute insult in a patient with pre-existing CKD.

Species affected

Both dogs and cats.
Important species differences:
  • Cats: ureteral obstruction, ureterolithiasis, lily toxicity, and pyelonephritis are particularly important.
  • Dogs: leptospirosis, ethylene glycol toxicity where relevant geographically, severe heat injury, infectious/inflammatory disease, and drug/toxin exposure are common concerns.

Predisposition

There is no single sex or breed predisposition to AKI overall. Predisposition is cause-specific:
Predisposing situationHigher-risk patients
LeptospirosisUnvaccinated or incompletely vaccinated dogs, outdoor/rodent-exposed dogs, endemic areas
Ureteral obstructionCats, especially with calcium oxalate ureteroliths
Nephrotoxic injuryHospitalized, hypotensive, dehydrated, septic, geriatric, or pre-existing CKD patients
Lily toxicosisCats only. Any suspected ingestion is an emergency
NSAID-associated AKIDehydrated, hypotensive, CKD, geriatric, anaesthetized, or concurrently nephrotoxin-exposed patients
Ischaemic injuryShock, haemorrhage, sepsis, heatstroke, pancreatitis, anaesthesia-related hypotension

Epidemiology and major causes

Prerenal causes
  • Vomiting, diarrhoea, poor intake
  • Haemorrhage
  • Shock, sepsis, anaphylaxis
  • Severe dehydration
  • Reduced effective circulating volume: severe cardiac disease, third spacing
  • Hypotension under anaesthesia
Intrinsic renal causes
  • Ischaemic acute tubular injury
  • Nephrotoxins: NSAIDs, aminoglycosides, radiographic contrast in at-risk patients, grapes/raisins in dogs, lilies in cats, ethylene glycol, vitamin D/cholecalciferol products
  • Infectious: leptospirosis, pyelonephritis, bacterial sepsis
  • Pigment nephropathy: haemoglobinuria/myoglobinuria
  • Glomerular, vascular, interstitial, infiltrative, or immune-mediated disease
  • Hypercalcaemia
Postrenal causes
  • Urethral obstruction
  • Bilateral ureteral obstruction, or unilateral obstruction in a solitary functioning kidney
  • Uroabdomen
  • Urolithiasis, strictures, neoplasia, blood clots
  • Iatrogenic ureteral ligation or trauma

Pathogenesis: step-by-step

  1. Initial insult reduces perfusion, directly injures tubular cells, or prevents urine leaving the urinary tract.
  2. GFR falls because renal perfusion falls, intratubular pressure rises, or nephrons are damaged.
  3. Tubular dysfunction develops. Tubules cannot reabsorb water, sodium, bicarbonate, and nutrients normally, or excrete potassium, acids, phosphorus, and waste products.
  4. Azotaemia and uraemia develop. Urea and creatinine rise, but creatinine may lag 24-48 hours behind injury.
  5. Electrolyte and acid-base abnormalities develop. Hyperkalaemia, hyperphosphataemia, metabolic acidosis, and sometimes hypocalcaemia are common in severe low-output AKI.
  6. Systemic consequences follow: nausea, vomiting, anorexia, GI mucosal injury, weakness, hypertension or hypotension, arrhythmias, pulmonary oedema if fluid overloaded, and neurologic signs in severe uraemia.
  7. Recovery is possible if surviving nephrons regain function. Recovery is often polyuric, so dehydration and hypokalaemia may then become major risks.
Simple concept: damaged kidneys either cannot filter, cannot concentrate, cannot regulate electrolytes, or cannot eliminate toxins. In oliguric AKI, adding more fluid does not “wash out” damaged kidneys. It can cause pulmonary oedema. “Fluid dena hai, but fluid overload nahi karna.”

Why the signs occur

Clinical signWhy it happens
Lethargy, weaknessUraemia, dehydration, acidosis, anaemia if chronic component, electrolyte disorders
Vomiting, nausea, hypersalivationUraemic toxins, gastritis, altered GI motility
AnorexiaNausea, altered taste, uraemia, pain
PU/PDTubular dysfunction and inability to concentrate urine, especially during recovery
Oliguria/anuriaMarkedly decreased GFR, obstruction, or severe renal injury
Halitosis/oral ulcersUraemic mucosal injury
Bradycardia/arrhythmiaHyperkalaemia
TachypnoeaMetabolic acidosis, pain, pulmonary oedema, or concurrent disease
HypertensionRAAS activation, sodium/water handling abnormalities, pain/stress
Oedema/serous effusionFluid overload, hypoalbuminaemia, severe renal dysfunction

2. HISTORY TAKING: CLINIC CHECKLIST

Immediate triage questions

Ask these before a long history:
  • Is the patient producing urine? When was the last normal urination?
  • Is there repeated straining with little or no urine?
  • Has there been sudden collapse, profound weakness, slow heart rate, or dyspnoea?
  • Could the cat have accessed lilies?
  • Could the dog have eaten grapes/raisins, antifreeze, rodenticide, human medication, or unknown chemicals?
  • Has there been NSAID, aminoglycoside, chemotherapy, contrast, or anaesthetic exposure?
  • Is leptospirosis possible? Rodents, stagnant water, wildlife, farm exposure, local outbreaks?

Ready-to-use owner history checklist

Presenting complaint and time course

  • What changed first: vomiting, anorexia, reduced urine, increased drinking, lethargy, collapse?
  • Exact onset and rate of progression?
  • Sudden onset or chronic weight loss/PU-PD before this illness?
  • Any previous abnormal renal values or diagnosis of CKD?

Appetite, water, urine, faeces

  • Appetite: reduced, absent, selective, painful swallowing?
  • Water intake: increased, reduced, or unable to keep water down?
  • Urination: frequency, volume, straining, dysuria, haematuria, inappropriate urination, last confirmed urine?
  • Defecation: diarrhoea, melaena, constipation?
  • Vomiting: frequency, blood/coffee-ground material, relation to food?
  • Estimate fluid loss: vomiting/diarrhoea frequency and volume.

Systemic signs

  • Lethargy, weakness, collapse, tremors, seizures?
  • Cough, tachypnoea, or exercise intolerance?
  • Fever, pain, lameness, jaundice?
  • Weight loss, chronic PU/PD, poor coat?

Exposure history

  • Any access to:
    • Lilies, grapes/raisins, antifreeze, vitamin D products?
    • Human painkillers, especially NSAIDs?
    • Rat poisons, pesticides, chemicals?
    • Contaminated water, rodents, wildlife, farms?
  • Tick/flea exposure and travel?
  • Boarding, shelter, new pets, dog parks?
  • Trauma, pelvic injury, recent surgery?

Previous medical and medication history

  • CKD, heart disease, diabetes, hyperthyroidism, pancreatitis, pyometra, urinary stones, FLUTD?
  • Recent hospitalisation or anaesthesia?
  • Medication name, strength, dose, frequency, last dose:
    • NSAIDs
    • ACE inhibitors/ARBs
    • Diuretics
    • Aminoglycosides
    • Chemotherapy
    • Steroids
    • Supplements/herbals
  • Vaccination status, especially Leptospira vaccination in dogs.
  • Deworming and parasite control.
  • Reproductive history if relevant: intact female with possible pyometra; pregnancy/lactation.

3. CLINICAL EXAMINATION

Triage first: ABC

  • Airway: patency, mentation, vomiting/aspiration risk.
  • Breathing: respiratory rate/effort, crackles, oxygen saturation, pulmonary oedema.
  • Circulation: heart rate/rhythm, pulses, blood pressure, mucous membranes, CRT, temperature.

Specific examination findings

AreaWhat to assessAKI significance
TPRFever, hypothermia, tachycardia, bradycardia, tachypnoeaFever may suggest pyelonephritis/leptospirosis/sepsis; bradycardia may signal hyperkalaemia; hypothermia is a poor perfusion/sepsis marker
Mucous membranes/CRTPale, injected, tacky, dry, uremic ulcers; CRTDehydration/hypoperfusion, anaemia, shock, uraemic oral disease
HydrationSkin tent, tacky gums, globe position, body weightEstimate deficit but do not rely on skin turgor alone in geriatric/obese animals
Body condition/muscle massCachexia, muscle wasting, obesityMuscle wasting may falsely lower creatinine; chronic wasting supports CKD or chronic disease
CardiovascularHR/rhythm, pulse quality, BP, jugular distensionHypotension worsens AKI; hypertension causes retinal/CNS injury; arrhythmia suggests hyperkalaemia
RespiratoryCrackles, increased effort, SpO₂Suspect fluid overload, aspiration, pulmonary oedema, acidosis
AbdomenKidney size/pain, bladder size, pain, free fluidEnlarged painful kidneys: AKI/pyelonephritis/infiltration; small irregular kidneys: CKD; large firm bladder: obstruction; free fluid: uroabdomen
UrogenitalPenis/prepuce/vulva, urethra, perineumLook for obstruction, trauma, discharge
NeurologicMentation, weakness, tremors, seizuresUraemic encephalopathy, hypertension, hypocalcaemia, toxins
EyesFundic exam, retinal haemorrhage/detachmentHypertensive emergency
Oral cavityUlcers, halitosis, dehydrationUraemia; also check for caustic toxin injury
SkinOedema, petechiae, dehydration, toxin contaminationFluid overload, coagulopathy, exposure clues
Lymph nodesEnlargementInfection, neoplasia, systemic inflammation

Pain assessment

Look for:
  • Renal palpation pain
  • Abdominal guarding
  • Tense posture
  • Hunched stance
  • Vocalisation
  • Hypertension/tachycardia from pain
Use validated pain scoring where possible. Avoid NSAIDs in suspected AKI.

4. DIFFERENTIAL DIAGNOSIS

The emergency rule

Before calling a patient “renal AKI,” rule out:
  1. Hypovolaemia/shock
  2. Urinary obstruction
  3. Uroabdomen
  4. Hyperkalaemia
  5. Sepsis/leptospirosis
  6. Toxin exposure

Azotaemia comparison

FeaturePrerenal azotaemiaIntrinsic renal AKIPostrenal azotaemia
Main problemReduced renal perfusionNephron injuryUrine cannot exit normally
Volume statusOften dehydrated/hypovolaemicVariableVariable
USGOften concentrated if tubular function intactOften inadequately concentratedVariable
Response to rehydrationRapid improvement if pure prerenalPersists or worsensPersists until obstruction/leak is corrected
Urine outputOften low initiallyLow, normal, or highOften low/anuric, stranguria may occur
ImagingUsually normalMay show renomegaly, altered architectureDilated renal pelves/ureters, distended bladder, effusion
Key treatmentRestore perfusionTreat cause + supportive careDecompress/repair obstruction or leak

Important and life-threatening differentials

DifferentialClinical cluesKey tests/findings
Urethral obstructionStranguria, repeated litter-box visits, painful distended bladder, hyperkalaemic bradycardiaPalpation, POCUS, ECG, potassium
Bilateral ureteral obstructionCat with acute anorexia/vomiting, small or normal bladder, painful kidneysUltrasound: pyelectasia/hydroureter; CT/contrast studies if needed
UroabdomenTrauma/surgery, abdominal distension, shock, oliguriaEffusion creatinine and potassium higher than serum
LeptospirosisFever, vomiting, AKI with hepatic or pulmonary involvement, exposure riskPCR/serology paired with clinical context
PyelonephritisFever, renal pain, pyuria/bacteriuria, systemic inflammationUrine culture before antibiotics, ultrasound
Ethylene glycolNeurologic signs early, severe acidosis, calcium oxalate monohydrate crystals may occurExposure history, acid-base status, toxin assay where available
Lily toxicosisAny cat with possible lily exposureTreat as emergency before confirmatory evidence
NSAID nephrotoxicityMedication access/overdose, dehydration or concurrent riskDrug history, GI injury, AKI trend
Acute-on-CKDPrior PU/PD/weight loss, small irregular kidneys, chronic non-regenerative anaemiaPrevious labs, imaging, chronicity markers
Addisonian crisisWeakness, vomiting, bradycardia, hyperkalaemia, hyponatraemiaElectrolyte pattern, ACTH stimulation testing after stabilization
Pancreatitis/sepsisPain, vomiting, hypotension, inflammationImaging, Spec cPL/fPL as clinically indicated, cultures/source investigation

5. CBC INTERPRETATION

CBC changes in AKI are usually nonspecific. They identify complications and causes rather than confirm AKI.
ParameterPossible AKI-associated findingClinical meaning
PCV/HCT, Hb, RBCIncreased with dehydration; decreased with haemorrhage, chronic kidney disease, inflammation, haemolysisHemoconcentration may mask anaemia. Low HCT on presentation can indicate chronicity, bleeding, or severe inflammatory disease
MCV/MCHCUsually normalMacrocytosis/hypochromasia suggests regeneration; microcytosis may suggest iron deficiency/chronic blood loss
ReticulocytesOften low if CKD-associated anaemia; high if haemorrhage/haemolysisTrue AKI alone does not immediately create marked erythropoietin-deficiency anaemia
WBC/neutrophilsNeutrophilia, left shift, toxic change with infection/sepsisSupports pyelonephritis, leptospirosis, pancreatitis, tissue injury, sepsis
NeutropeniaConsumption/sepsisGrave finding if accompanied by toxic change and instability
LymphocytesLymphopenia common with stressNonspecific. Lymphocytosis can occur with hypoadrenocorticism
MonocytesMonocytosis in inflammation/stressSupports inflammatory disease but is nonspecific
EosinophilsEosinophilia may support hypoadrenocorticism or parasitesInterpret with clinical context
PlateletsThrombocytopenia in sepsis, DIC, leptospirosis, immune-mediated diseaseConfirm with blood smear because clumping is common, especially in cats

Pattern recognition

  • Regenerative anaemia: reticulocytosis, polychromasia, anisocytosis. Think bleeding or haemolysis.
  • Non-regenerative anaemia: inadequate reticulocyte response. CKD, chronic inflammation, marrow disease.
  • Left shift: increased immature neutrophils. Indicates high tissue demand/inflammation.
  • Toxic neutrophils: accelerated marrow release, commonly severe inflammation/sepsis.
  • Neutrophilia: stress, inflammation, steroid effect, infection.
  • Neutropenia with toxic change: potentially overwhelming sepsis.
  • Thrombocytopenia: verify manually, then consider leptospirosis, DIC, sepsis, immune destruction.

6. SERUM BIOCHEMISTRY AND BLOOD GAS INTERPRETATION

Core AKI pattern

ParameterExpected changeMechanism and importance
BUN/ureaIncreasedReduced filtration, catabolism, GI bleeding, dehydration. Less specific than creatinine
CreatinineIncreased or rising seriallyReduced GFR. May initially be normal after acute insult; affected by muscle mass
SDMAIncreasedReduced GFR; may rise earlier than creatinine, but interpret trends and assay/lab context
PhosphorusIncreasedReduced excretion. Severe hyperphosphataemia suggests severe reduction in GFR/cell injury
PotassiumHigh in oliguric/anuric AKI or obstruction; low in recovery/polyuric phaseHyperkalaemia can cause fatal arrhythmia. Hypokalaemia worsens weakness and renal tubular function
Sodium/chlorideVariableVomiting, fluid type, obstruction, adrenal disease, renal losses all influence values
Bicarbonate/total CO₂Often decreasedMetabolic acidosis from reduced acid excretion and poor perfusion
Anion gapOften increasedRetained acids, lactate, uraemic toxins
CalciumTotal calcium variable; ionised calcium may be low/normal/highInterpret ionised calcium when clinically relevant. Hypercalcaemia can cause AKI and must be investigated
Albumin/total proteinHigh with dehydration; low with protein loss, inflammation, effusionHelps assess hydration and concurrent disease
ALT/AST/ALP/GGT/bilirubinVariableMay point toward leptospirosis, hypoperfusion, hepatobiliary disease, pancreatitis, haemolysis
GlucoseHigh with stress; low with sepsis or severe hepatic diseaseHypoglycaemia is an emergency clue in septic/toxic patients
Cholesterol/triglyceridesVariableNot primary AKI markers; may support protein-losing or endocrine disease
Amylase/lipaseMay increase with reduced renal clearanceDo not diagnose pancreatitis from nonspecific increases alone
Spec cPL/fPLUse only when pancreatitis is a meaningful differentialInterpret with imaging and clinical signs

Hyperkalaemia: immediate interpretation

Obtain an ECG if potassium is significantly high, rising, or patient is bradycardic/weak.
Potential ECG changes:
  • Tall tented T waves
  • Shortened QT
  • Prolonged PR
  • QRS widening
  • Loss of P waves
  • Ventricular arrhythmias or sine-wave pattern
Treat the patient and ECG, not a single potassium value alone.

Blood gas and lactate

  • Venous blood gas: pH, bicarbonate, base excess, potassium, ionised calcium.
  • Lactate: perfusion marker, not a direct renal marker.
  • Severe metabolic acidaemia requires cause-directed treatment. Bicarbonate is not routine for every AKI patient.

7. URINALYSIS

Collect urine before antimicrobial therapy whenever feasible, but never delay life-saving stabilization for sampling.
UA elementAKI relevance
USGInappropriately low USG in an azotaemic patient supports renal dysfunction, but early AKI may still have concentrated urine
pHVariable; alkaline urine with pyuria/bacteriuria can support infection but is not diagnostic
ProteinMay reflect tubular injury, glomerular disease, inflammation, haematuria, or infection. Interpret UPC only after sediment is inactive
GlucoseNormoglycaemic glucosuria supports proximal tubular dysfunction, for example Fanconi syndrome or toxic tubular injury
KetonesConsider diabetic ketoacidosis, starvation, or severe illness
Blood/RBCsTrauma, cystocentesis, stones, infection, obstruction, neoplasia, pigment
WBCsPyuria supports inflammation/infection but is not synonymous with bacterial UTI
BacteriaConfirm with culture. Consider contamination, especially with voided samples
CastsGranular casts and renal tubular epithelial cell casts support tubular injury; absence does not exclude AKI
CrystalsCalcium oxalate monohydrate may support ethylene glycol exposure; calcium oxalate/uroliths may support obstruction. Crystalluria alone is not diagnostic
BilirubinSmall amounts can be normal in concentrated canine urine; interpret cautiously, especially in cats
Sediment“Active” sediment may indicate pyelonephritis, urolithiasis, haemorrhage, or inflammation

Important clinical cautions

  • USG cannot by itself distinguish AKI from CKD.
  • Collect urine for culture and susceptibility when pyelonephritis is possible.
  • UPC is best deferred until haematuria, pyuria, bacteriuria, and marked postrenal protein contamination are controlled.
  • A normal urine sediment does not exclude AKI.

8. PRACTICAL DIAGNOSTIC PLAN

First 5-15 minutes

  1. ABC assessment.
  2. Place IV catheter, obtain blood and urine samples if this does not delay stabilization.
  3. Check:
    • Bedside glucose
    • PCV/TS
    • Electrolytes, especially potassium
    • Blood gas/acid-base if available
    • Blood pressure
    • ECG if hyperkalaemia/bradycardia
  4. Palpate bladder and kidneys.
  5. POCUS: bladder size, free abdominal fluid, renal pelvis dilation, lung B-lines/effusion.

Minimum database

  • CBC with smear review
  • Serum biochemistry: BUN, creatinine, phosphorus, electrolytes, calcium, albumin, glucose, liver values
  • Blood gas and lactate in ill patients
  • Urinalysis with sediment and USG
  • Blood pressure
  • Accurate body weight
  • Urine output measurement
  • ECG if hyperkalaemic, bradycardic, or unstable

Recommended tests

  • Urine culture and susceptibility, ideally cystocentesis sample
  • Abdominal ultrasound
  • Abdominal radiographs
  • Serial creatinine, BUN, phosphorus, potassium, acid-base values
  • UPC after sediment is inactive if proteinuria persists
  • Leptospira PCR/serology as appropriate
  • Spec cPL/fPL when pancreatitis is plausible
  • Toxicology testing when it changes management
  • Coagulation testing if bleeding/DIC is possible

Severe/emergency tests

  • ECG and continuous rhythm monitoring
  • Serial blood gases/electrolytes
  • Thoracic radiographs or lung ultrasound if fluid overload is suspected
  • Abdominocentesis if free fluid is present:
    • Compare abdominal-fluid creatinine and potassium with serum for uroabdomen
  • Crossmatch/type if transfusion could be required
  • Blood cultures when bacteraemia/sepsis is a credible concern, ideally before antibiotics

Confirmatory approach

AKI is generally a clinical diagnosis based on abrupt renal dysfunction, serial changes, urine output, and exclusion of prerenal/postrenal causes. There is no single definitive AKI test.

9. IMAGING

Radiography

Recommended views

  • Abdominal right lateral
  • Abdominal left lateral
  • Ventrodorsal or dorsoventral view

Look for

  • Renal size and shape
  • Radiopaque uroliths
  • Bladder distension
  • Loss of abdominal serosal detail suggesting effusion
  • Prostatic enlargement, masses, trauma
  • Mineralized ureteral calculi, though many are not visible
Radiographs are limited for ureteral obstruction and renal parenchymal disease.

Ultrasound

Use early when obstruction, pyelonephritis, nephrolithiasis, renal size change, mass, or uroabdomen is suspected.
Possible AKI findings:
  • Renomegaly
  • Increased cortical echogenicity
  • Medullary rim sign, nonspecific
  • Pyelectasia/hydronephrosis
  • Hydroureter
  • Renal/ureteral calculi
  • Perirenal fluid
  • Irregular renal contour or small kidneys, supporting chronic disease
  • Renal pelvic debris in pyelonephritis, but not diagnostic alone
Important: normal ultrasound does not exclude AKI or pyelonephritis. Pyelectasia can be physiologic, especially after fluid therapy. Interpret with clinical context and serial imaging.

CT

Useful for:
  • Suspected ureteral obstruction not fully characterized by ultrasound/radiographs
  • Complex stone mapping
  • Surgical/interventional planning
  • Renal/ureteral anomalies or masses
Use contrast cautiously and only when benefit outweighs risk. Avoid assuming contrast is harmless in unstable AKI.

Echocardiography

Not a renal diagnostic test, but useful when:
  • Fluid intolerance is suspected
  • Cardiac disease complicates resuscitation
  • Hypertension, pulmonary oedema, or shock is present

MRI

Rarely required for primary AKI. Use for neurologic complications or specific infiltrative/vascular questions.

10. DIAGNOSIS

Presumptive AKI

A sudden onset of compatible illness plus:
  • Rising creatinine and/or SDMA
  • Reduced urine production or tubular dysfunction
  • Inappropriate urine concentration in an azotaemic patient
  • Supportive urine sediment/imaging
  • Compatible exposure or systemic disease

Definitive cause-based diagnosis

Examples:
  • Urethral obstruction: clinical exam plus catheterization/imaging.
  • Uroabdomen: abdominal fluid creatinine and potassium exceed serum values.
  • Pyelonephritis: compatible illness plus urine culture, ideally with imaging support.
  • Leptospirosis: appropriate PCR/serology plus clinical context.
  • Toxin exposure: credible exposure history, compatible findings, or assay.
  • Ureteral obstruction: ultrasound/CT/interventional findings.

IRIS AKI grading

After hydration status and postrenal obstruction are addressed, IRIS grades AKI I-V using creatinine, serial change, and clinical parameters including urine output. Broadly:
  • Grade I: non-azotaemic AKI with documented renal injury or a relevant rising creatinine trend.
  • Grades II-V: increasing severity of azotaemia.
  • Subcategorize as oliguric, non-oliguric, or anuric, and identify need for renal replacement therapy.
Use the current IRIS AKI resource, rather than relying on a single creatinine measurement.

Conflicting results

  • High creatinine plus dehydration: may be prerenal, AKI, CKD, or mixed. Reassess after controlled rehydration.
  • Normal creatinine with poor urine output: early AKI, low muscle mass, or obstruction remains possible.
  • Concentrated urine: does not exclude early intrinsic AKI.
  • Dilute urine: may result from fluids, diuretics, endocrine disease, CKD, or AKI.
  • Small kidneys plus abrupt deterioration: acute-on-CKD is likely.
  • Azotaemia improves after unblocking: postrenal component was present, but renal injury can persist.

Common diagnostic mistakes

  • Calling all azotaemia “kidney failure.”
  • Missing ureteral obstruction in a cat with a small bladder.
  • Diagnosing UTI from pyuria without urine culture.
  • Assuming normal creatinine excludes early AKI.
  • Mistaking fluid-induced haemodilution for renal recovery.
  • Missing hypertension and retinal injury.
  • Ignoring medication and toxin history.
  • Giving nephrotoxic drugs before collecting essential samples or assessing renal status.

11. TREATMENT PROTOCOL

Treatment priorities

  1. Stabilize ABCs.
  2. Correct hypovolaemia and hypotension.
  3. Stop nephrotoxins.
  4. Relieve obstruction or repair urine leakage.
  5. Treat hyperkalaemia, dangerous acidosis, and fluid overload.
  6. Identify and treat the cause.
  7. Provide antiemesis, nutrition, analgesia, and intensive monitoring.
  8. Refer early for ureteral intervention or renal replacement therapy when indicated.

A. Mild AKI

Typical profile: non-oliguric, stable perfusion, mild azotaemia, no dangerous electrolyte derangement.
  • Hospitalize or closely supervise depending on cause and trend.
  • Stop nephrotoxins.
  • Address dehydration with individualized balanced isotonic crystalloid therapy.
  • Monitor creatinine, electrolytes, body weight, urine output, and BP.
  • Treat nausea/pain.
  • Investigate cause: culture, imaging, infectious/toxin testing as indicated.
  • Ensure enteral nutrition as soon as vomiting is controlled.

B. Moderate AKI

Typical profile: progressive azotaemia, vomiting/anorexia, electrolyte changes, significant dehydration, or suspected infection/toxin.
  • Hospitalize with strict input-output charting.
  • IV fluid plan tailored to deficit, ongoing losses, urine output, and cardiovascular tolerance.
  • Urinary catheter if necessary for accurate output, using aseptic technique and removing as soon as practical.
  • Urine culture before antibiotics when feasible.
  • Serial electrolyte, acid-base, BP, body weight assessments.
  • Early referral discussion if creatinine rises despite correction of perfusion, oliguria develops, or ureteral disease is suspected.

C. Severe/critical AKI

Typical profile: oliguria/anuria, severe hyperkalaemia/acidosis, pulmonary oedema, severe uraemia, hypertension, neurological signs, obstruction, septic shock.
  • ICU-level care.
  • ECG and frequent blood gas/electrolyte monitoring.
  • Treat hyperkalaemic cardiotoxicity immediately when ECG changes/bradyarrhythmia are present.
  • Avoid blind high-rate fluid administration.
  • Relieve postrenal obstruction urgently.
  • Consult/referral for intermittent haemodialysis, continuous renal replacement therapy, or peritoneal dialysis early rather than after prolonged deterioration.

D. Emergency/ICU management: first-hour checklist

  • Oxygen if hypoxaemic or in respiratory distress.
  • IV access, blood pressure, ECG if indicated.
  • Bedside electrolytes/blood gas/glucose.
  • Palpate bladder, POCUS abdomen and lungs.
  • Controlled isotonic crystalloid boluses only if hypovolaemic.
  • Hyperkalaemia protocol if indicated.
  • Urinary catheter/decompression if urethral obstruction.
  • Abdominocentesis if uroabdomen suspected.
  • Analgesia and antiemetic therapy.
  • Infection control precautions when leptospirosis is possible.

Drug table: standard reference-style doses

These are educational reference ranges, not automatic prescriptions. Choose therapy from the patient’s perfusion, ECG, potassium, acid-base status, urine output, cause, concurrent disease, local formulary, and monitoring capacity.
DrugClass/indicationReference doseKey cautions/monitoring
MaropitantNK1 antiemetic1 mg/kg IV or SC q24hUse for vomiting/nausea. Does not replace investigation of GI obstruction or pancreatitis. Monitor comfort at injection
Ondansetron5-HT3 antiemetic0.1-0.2 mg/kg IV q8-12hUseful for refractory nausea. Consider QT risk and drug interactions in predisposed patients
MetoclopramideProkinetic/antiemetic1-2 mg/kg/day IV CRIAvoid if GI obstruction/perforation suspected; may cause agitation or dysphoria
BuprenorphineOpioid analgesic0.01-0.02 mg/kg IV, IM, or transmucosally q6-8hGood feline option. Sedation, dysphoria, reduced GI motility possible
MethadoneOpioid analgesic0.1-0.3 mg/kg IV/IM q4-6hDose to effect. Monitor sedation, ventilation, dysphoria
Calcium gluconate 10%Cardiac membrane stabilizer in hyperkalaemia50-100 mg/kg IV slowly over 10-20 min with ECG monitoringDoes not lower potassium. Stop if bradyarrhythmia worsens; avoid extravasation
Regular insulin plus dextroseShifts potassium intracellularlyRegular insulin 0.1 U/kg IV, paired with dextrose per protocolCheck glucose every 1-2 hours initially. Hypoglycaemia is the major risk
TerbutalineBeta-2 agonist, potassium shift0.01 mg/kg SCMay cause tachycardia, tremors. Adjunct, not definitive therapy
FurosemideLoop diureticA cautious diagnostic/therapeutic trial may be considered only after euvolaemia and obstruction are addressedIt does not repair AKI or improve renal recovery. Monitor BP, volume, electrolytes, urine output. Avoid escalating repeatedly in anuric, overloaded patients
Ampicillin/amoxicillinAntibiotic when bacterial infection is supported/suspectedSelection and dose should follow culture, site, severity, and renal adjustmentNot indicated for uncomplicated sterile AKI. Obtain culture first when possible
DoxycyclineUsed to eliminate renal carriage after initial treatment for canine leptospirosis5 mg/kg PO q12h for 14 days is a commonly used protocolGI adverse effects; administer with water/food. Use after patient can tolerate oral medication and follow local infectious-disease guidance

Drugs usually avoided or used only with strong justification

  • NSAIDs: avoid in suspected AKI.
  • Aminoglycosides: avoid unless no safer option and use therapeutic drug monitoring.
  • ACE inhibitors/ARBs: do not start during unstable AKI/hypotension.
  • Mannitol: not routine; can worsen fluid overload and is inappropriate in anuric/fluid-overloaded patients.
  • Dopamine “renal-dose”: do not use simply to “improve renal perfusion.” It has not shown reliable renal-protective benefit.
  • Empirical antibiotics: do not prescribe merely because AKI is severe.
A current review emphasizes tailored fluids, urine output and BP surveillance, nutritional support, and cause-specific treatment rather than forced diuresis. See AKI management review.

12. FLUID THERAPY

The principle

Fluid therapy has three distinct aims:
  1. Restore intravascular volume if hypovolaemic.
  2. Correct interstitial dehydration deficit.
  3. Replace maintenance needs plus measured ongoing losses.
After those goals are met, target near-zero fluid balance: input should approximately match output. The current AKI literature stresses early correction of true hypovolaemia while preventing iatrogenic overload in low-output patients.

Fluid selection

  • Balanced isotonic crystalloids are appropriate in many AKI patients.
  • 0.9% saline may be selected when clinically indicated, but excessive chloride exposure can worsen hyperchloraemic acidosis.
  • Choice should be based on sodium, chloride, acid-base status, concurrent disease, and availability.
  • Do not avoid balanced crystalloid solely because it contains a small amount of potassium. The potassium concentration in common balanced fluids is usually far lower than the patient’s plasma potassium and does not generally drive emergency hyperkalaemia management.
  • Add potassium only after documented need and careful calculation. Never add potassium to fluids in a hyperkalaemic or anuric patient.

Shock resuscitation: titrated, not blind

In AKI or suspected AKI, give smaller aliquots and reassess:
  • Dog: 10-15 mL/kg isotonic crystalloid over 10-15 minutes.
  • Cat: 5 mL/kg over 10-15 minutes.
Reassess after each bolus:
  • HR/rhythm and pulse quality
  • Mentation
  • BP/MAP
  • CRT and mucous membranes
  • Lung sounds/POCUS B-lines
  • Respiratory effort/SpO₂
  • Body weight
  • Urine output
If hypotension persists after volume status is reasonable, investigate vasodilation/sepsis/cardiac dysfunction and consider vasoactive support in ICU rather than repeated fluid boluses.

Deficit calculation

Fluid deficit (mL) = body weight (kg) × dehydration fraction × 1000
Example: 10 kg dog, estimated 8% dehydrated
10 × 0.08 × 1000 = 800 mL deficit
Replace over a clinically appropriate period, commonly over about 6-12 hours if cardiovascularly tolerated, while counting all fluids already administered.

Maintenance

A practical hospitalized starting estimate is often about 2-3 mL/kg/hr, then adjust. It is not a mandatory rate.

Example maintenance estimates

PatientAt 2 mL/kg/hrAt 3 mL/kg/hr
2 kg cat4 mL/hr6 mL/hr
5 kg cat10 mL/hr15 mL/hr
10 kg dog20 mL/hr30 mL/hr
20 kg dog40 mL/hr60 mL/hr
30 kg dog60 mL/hr90 mL/hr
For an oliguric/anuric patient, do not automatically give full maintenance. Base fluid delivery on measured losses, urine output, insensible losses, nutrition, electrolyte needs, and frequent reassessment.

Ongoing loss replacement

Ongoing loss replacement = measured urine + vomitus + diarrhoea + drain losses, adjusted by clinical reassessment.
Example: 10 kg dog after stabilization:
  • Urine output: 0.8 mL/kg/hr = 8 mL/hr
  • Estimated maintenance: 20 mL/hr
  • Vomiting: 20 mL over 4 hours = 5 mL/hr
Estimated hourly requirement: 8 + 20 + 5 = 33 mL/hr, then reassess frequently.
If this dog is fluid overloaded or oliguric, this formula must be revised downward and referral considered.

Urine output targets

  • Expected normal urine output in hospitalized patients is often roughly 1-2 mL/kg/hr.
  • Persistent oliguria is concerning. Confirm catheter patency, bladder emptying, hydration, BP, obstruction status, and measurement accuracy before adding drugs.
  • Persistent anuria or very low urine output despite appropriate optimization requires urgent reassessment and often referral.

Stop or reduce fluids when

  • Deficits are corrected.
  • BP/perfusion is adequate.
  • Urine output is low and body weight is increasing.
  • New tachypnoea, crackles, pleural effusion, pulmonary oedema, or increased B-lines develop.
  • Peripheral oedema, chemosis, serous nasal discharge, or worsening hypertension occurs.
  • PCV/TS falls from dilution without clinical improvement.

Fluid overload signs

  • Rapid weight gain
  • Increased RR/effort
  • Crackles, B-lines, pulmonary oedema
  • Pleural effusion
  • Chemosis, peripheral oedema
  • Worsening hypertension
  • Serous nasal discharge
  • New oxygen requirement

13. DOSE CALCULATIONS

Formula

Dose (mg) = body weight (kg) × dose (mg/kg)

Worked example: maropitant 1 mg/kg

This is an example of arithmetic, not an instruction to use maropitant in every patient.
PatientCalculationDose
2 kg cat2 × 1 mg/kg2 mg
5 kg cat5 × 1 mg/kg5 mg
10 kg dog10 × 1 mg/kg10 mg
20 kg dog20 × 1 mg/kg20 mg
30 kg dog30 × 1 mg/kg30 mg

Worked example: buprenorphine 0.02 mg/kg

PatientCalculationDose
2 kg cat2 × 0.020.04 mg
5 kg cat5 × 0.020.10 mg
10 kg dog10 × 0.020.20 mg
20 kg dog20 × 0.020.40 mg
30 kg dog30 × 0.020.60 mg

Converting mg to mL

Volume (mL) = required dose (mg) ÷ product concentration (mg/mL)
I have intentionally not converted these doses to mL because injectable and oral product concentrations vary by country and manufacturer. Use the exact concentration printed on your product label.
Example format:
  • Required dose: 10 mg
  • Label concentration: ___ mg/mL
  • Volume: 10 ÷ ___ = ___ mL
For a real patient, provide the drug name, formulation, and label concentration, and the calculation can be checked exactly.

14. SUPPORTIVE CARE

Nutrition

  • Do not prolong starvation because of nausea alone.
  • Control vomiting/nausea first, then start early enteral nutrition if safe.
  • In acute critical illness, prioritize adequate calories and protein rather than automatically imposing severe protein restriction.
  • Use feeding tubes when the GI tract is usable and voluntary intake is absent.
  • In cats, avoid prolonged anorexia because hepatic lipidosis can develop.
  • Renal therapeutic diets may be useful later, especially if CKD persists, but acute nutritional decisions must be individualized.

Antiemetics

Use maropitant, ondansetron, or metoclopramide according to clinical signs and contraindications. Reassess for GI obstruction, pancreatitis, uraemia, and drug adverse effects.

Analgesia

  • Prefer opioids titrated to effect.
  • Avoid NSAIDs in AKI.
  • Treat renal/ureteral pain, abdominal pain, and catheter-associated discomfort.

Gastroprotection

  • Do not give acid suppressants automatically to every uraemic patient.
  • Consider gastroprotective treatment for documented or strongly suspected GI ulceration, haematemesis, melaena, severe reflux, or other specific indication.
  • Sucralfate can interfere with absorption of other drugs, so separate administration times.

Antibiotics

Only when there is:
  • Pyelonephritis/UTI supported by culture or strong clinical evidence
  • Leptospirosis or credible bacterial infectious cause
  • Sepsis/bacteraemia
  • An infected urinary obstruction or urinary tract instrumentation complication

Electrolytes/vitamins

  • Correct potassium, magnesium, phosphate, sodium, calcium, and acid-base abnormalities based on measured values.
  • Do not add potassium “routinely.”
  • Phosphate binders are more relevant once enteral feeding occurs and hyperphosphataemia persists; they do not replace treating severe AKI or dialysis.
  • B vitamins may be considered in prolonged polyuric losses, but are not an AKI cure.

Oxygen

Indicated for hypoxaemia, dyspnoea, pulmonary oedema, severe anaemia, or shock.

Blood products

Indicated for clinically important haemorrhage, haemolysis, or severe symptomatic anaemia, not merely a mildly decreased PCV.

Nursing care

  • Accurate intake-output chart
  • Closed urine collection if catheterized
  • Catheter asepsis and daily need assessment
  • Turn recumbent patients regularly
  • Oral care for uraemic ulcers
  • Anti-nausea feeding plan
  • Daily weight, sometimes 2-4 times daily in unstable cases
  • Barrier nursing/PPE for suspected leptospirosis

15. ANTIBIOTIC STEWARDSHIP

When antibiotics are truly indicated

  • Positive urine culture with compatible pyelonephritis/UTI signs
  • Septic patient
  • Leptospirosis
  • Infected obstruction
  • Bacterial focus outside the urinary tract causing AKI

Best practice

  1. Obtain urine by cystocentesis for culture before antibiotics when patient stability allows.
  2. Choose empirical therapy based on illness severity, likely site, local resistance, and renal safety.
  3. Modify treatment promptly using culture/susceptibility results.
  4. Use the narrowest effective drug.
  5. Review renal dose adjustment and avoid nephrotoxic choices when alternatives exist.
  6. Do not diagnose pyelonephritis from pyuria alone.
  7. Repeat culture when clinically indicated, especially if response is poor or infection is complicated.

Avoid

  • “Preventive” antibiotics for sterile AKI.
  • Prolonged antibiotics without culture reassessment.
  • Aminoglycosides in unstable AKI unless there is no viable alternative and specialist-level monitoring is available.

16. PROGNOSIS

Prognosis depends more on cause, response, urine output, complications, and access to renal replacement therapy than on a single creatinine concentration.

Better prognostic indicators

  • Rapid correction of a prerenal cause
  • Relief of obstruction before severe prolonged injury
  • Improving creatinine trend
  • Return of appropriate urine output
  • Stable BP and electrolytes
  • Controlled infection/toxin exposure
  • Ability to eat and tolerate enteral nutrition
  • No severe comorbidity

Poor prognostic indicators

  • Persistent anuria/oliguria
  • Worsening azotaemia despite corrected perfusion
  • Refractory hyperkalaemia, acidosis, fluid overload, or hypertension
  • Severe systemic sepsis/MODS
  • Severe nephrotoxic injury
  • Advanced acute-on-CKD
  • Delayed presentation after lily or ethylene glycol exposure
  • Inability to access obstruction relief or renal replacement therapy when indicated
Reported survival varies widely, roughly 38%-66% in mixed AKI populations, reflecting differing causes, severity, referral patterns, and euthanasia decisions. See the clinical AKI review.

Refer urgently when

  • Suspected ureteral obstruction
  • Persistent oliguria/anuria
  • Refractory hyperkalaemia/acidosis
  • Fluid overload
  • Creatinine is rising in an appropriately hydrated patient
  • Need for haemodialysis/CRRT/peritoneal dialysis
  • Severe hypertension, pulmonary oedema, or neurological uraemia

17. MONITORING SHEET

ParameterMild/stable AKIModerate AKISevere/ICU AKI
TPR, mentation, painEvery 4-6 hEvery 2-4 hContinuous/at least hourly
BPEvery 6-12 hEvery 2-4 hContinuous or every 1-2 h
ECGIf electrolyte riskIntermittent if K abnormalContinuous if significant hyperkalaemia/arrhythmia
SpO₂/RR/effortEvery 4-6 hEvery 2-4 hContinuous if unstable or overloaded
Urine outputEvery 4-6 hHourly where possibleHourly
Fluid input/outputEvery 4-6 hHourly to 2-hourlyHourly
Body weightDaily2 times dailyEvery 4-8 h if fluid balance is precarious
CBCDaily or as indicatedDaily12-24 h, or sooner if bleeding/sepsis
Electrolytes, glucose, blood gasDaily to 12-hourlyEvery 6-12 hEvery 2-6 h during instability
BUN/creatinine/phosphorusDailyEvery 12-24 hEvery 12-24 h, trend-based
UA/cultureAt baseline; repeat if indicatedBaseline + response drivenBaseline, then cause-driven
Lung ultrasound/radiographsIf respiratory changeIf fluid intolerance suspectedSerial as clinically indicated

18. COMMON CLINICAL MISTAKES

  1. Giving large-volume fluids to every azotaemic patient.
  2. Failing to document urine output.
  3. Mistaking oliguria from obstruction for intrinsic renal failure.
  4. Not palpating the bladder or using POCUS.
  5. Missing ureteral obstruction in cats because the bladder is small.
  6. Treating hyperkalaemia without ECG assessment when available.
  7. Giving calcium gluconate and assuming potassium has been corrected.
  8. Using furosemide repeatedly instead of reassessing perfusion, obstruction, and referral needs.
  9. Starting antibiotics without obtaining culture in a stable patient.
  10. Missing leptospirosis and exposing staff or other animals.
  11. Assuming a single normal creatinine excludes AKI.
  12. Failing to stop NSAIDs, aminoglycosides, and other nephrotoxins.
  13. Ignoring blood pressure and fundic examination.
  14. Underfeeding anorectic cats.
  15. Calling a patient “recovered” because creatinine briefly falls after haemodilution.

What you may miss if you focus only on AKI

  • Addisonian crisis
  • Uroabdomen
  • Pancreatitis/sepsis causing renal hypoperfusion
  • Hypertensive emergency
  • Cardiac disease limiting fluids
  • Acute-on-CKD
  • Pyometra
  • Hypercalcaemia
  • Severe toxic exposure needing antidotal therapy or decontamination
  • Obstructive uropathy requiring intervention, not more medical therapy

19. RED FLAGS

Immediate hospitalization

  • Persistent vomiting/anorexia with azotaemia
  • Oliguria or uncertain urine production
  • AKI with dehydration, pain, fever, or toxin exposure
  • Suspected pyelonephritis or leptospirosis
  • Progressive creatinine or phosphorus increase

Emergency stabilization

  • Bradycardia, weakness, or ECG changes with hyperkalaemia
  • Hypotension/shock
  • Urethral obstruction
  • Suspected uroabdomen
  • Any cat with possible lily ingestion
  • Severe acidosis
  • Dyspnoea or suspected fluid overload
  • Seizures, coma, severe uraemic encephalopathy

ICU/referral

  • Persistent urine output below approximately 0.3 mL/kg/hr for over 6 hours despite appropriate medical optimization
  • Anuria
  • Uncontrolled hyperkalaemia/acidosis
  • Refractory fluid overload
  • Rising creatinine despite corrected hydration/perfusion
  • Suspected bilateral ureteral obstruction
  • Need for dialysis or advanced interventional urology

Blood transfusion

  • Active significant haemorrhage
  • Severe symptomatic anaemia with poor oxygen delivery
  • Not solely because a patient has AKI or mild non-regenerative anaemia

Surgery/interventional procedure

  • Urethral obstruction not medically relieved
  • Uroabdomen
  • Ureteral obstruction requiring stent or subcutaneous ureteral bypass
  • Selected stones, strictures, masses, trauma

20. CASE SIMULATION

Case: do not scroll for an answer because none is provided yet

Signalment

Milo, 7-year-old neutered male domestic shorthair cat, 4.6 kg.

History

Presented for 36 hours of hiding, anorexia, intermittent vomiting, and reduced activity. The owner has seen small urine clumps but is uncertain whether Milo is urinating normally. No known lily exposure. Indoor-outdoor access. A previous urinary obstruction occurred 3 years ago. No current medication. The owner reports increased water intake over the preceding month.

Clinical examination

  • Quiet but responsive
  • Temperature: 37.4°C
  • HR: 156 bpm, regular
  • RR: 34/min, mildly increased but unlaboured
  • BP: 178 mmHg systolic, repeated after acclimation
  • Mucous membranes: tacky, pink; CRT 2 sec
  • Estimated dehydration: 6%
  • Kidneys palpably uncomfortable; left kidney seems enlarged
  • Bladder: small to moderately sized, non-turgid
  • Mild oral halitosis, no ulcers
  • No heart murmur; lung sounds clear

CBC

TestResult
PCV35%
Hb11.8 g/dL
RBC7.1 × 10¹²/L
MCV49 fL
MCHC33.5 g/dL
WBC18.9 × 10⁹/L
Neutrophils15.7 × 10⁹/L
Bands0.6 × 10⁹/L
Lymphocytes1.2 × 10⁹/L
Monocytes1.1 × 10⁹/L
PlateletsAdequate on smear

Biochemistry and blood gas

TestResult
BUN96 mg/dL
Creatinine6.2 mg/dL
SDMA52 µg/dL
Phosphorus9.8 mg/dL
Potassium5.9 mmol/L
Sodium150 mmol/L
Chloride113 mmol/L
Total calcium9.1 mg/dL
Albumin3.5 g/dL
Glucose127 mg/dL
ALT68 U/L
Venous pH7.27
HCO₃⁻15 mmol/L
Lactate2.4 mmol/L

Urinalysis

Cystocentesis sample before antimicrobials:
  • USG: 1.018
  • Protein: 2+
  • Blood: 1+
  • Glucose: negative
  • Ketones: negative
  • Sediment: 10-15 WBC/hpf, 5-10 RBC/hpf, rare granular casts, no visible bacteria
  • Urine submitted for culture and susceptibility

Imaging

Abdominal ultrasound:
  • Left renal pelvis: 8 mm dilation
  • Proximal left ureter mildly dilated
  • 2 mm hyperechoic focus with distal acoustic shadowing near proximal ureter
  • Right renal pelvis: 2 mm dilation
  • Both kidneys mildly irregular; left kidney enlarged
  • Urinary bladder small, no obvious urolith
  • No free abdominal fluid

Your tasks

  1. Identify the major problem list.
  2. List and prioritize differentials.
  3. Interpret the CBC.
  4. Interpret the biochemistry and blood gas.
  5. Select further tests and explain why.
  6. Give your presumptive diagnosis.
  7. Create an emergency and ongoing treatment plan.
  8. Calculate doses for antiemetic, analgesic, and any indicated hyperkalaemia treatment.
  9. Create a monitoring plan for the first 24 hours.
  10. Give prognosis and referral recommendation.
Reply with your reasoning in numbered sections. I will assess it like a senior clinician, identify unsafe assumptions, and provide corrections.

21. QUICK CLINICAL ALGORITHM

AZOTAEMIC / VOMITING / OLIGURIC DOG OR CAT
                |
                v
1. TRIAGE ABCs
   - BP, ECG if K high/bradycardia, glucose, blood gas, oxygen if needed
                |
                v
2. IS THERE AN IMMEDIATE POSTRENAL EMERGENCY?
   - Palpate bladder, POCUS, assess for uroabdomen
   - Obstruction or urine leak -> decompress/repair/referral
                |
                v
3. IS THE PATIENT HYPOVOLAEMIC OR HYPOTENSIVE?
   - Small crystalloid bolus, reassess after each aliquot
   - Correct deficit carefully
                |
                v
4. MINIMUM DATABASE
   - CBC, chemistry, electrolytes, phosphorus, UA/culture, BP
   - Urine output, imaging, serial creatinine/SDMA
                |
                v
5. CLASSIFY
   - Prerenal, intrinsic renal, postrenal, or mixed
   - Identify cause: toxin, infection, ischaemia, obstruction, acute-on-CKD
                |
                v
6. TREAT COMPLICATIONS
   - Hyperkalaemia/ECG changes
   - Acidosis
   - Nausea, pain, hypertension, fluid overload
                |
                v
7. TARGETED THERAPY
   - Antidote/decontamination, antimicrobials only if indicated,
     relieve obstruction, treat sepsis or leptospirosis
                |
                v
8. MONITOR HOURLY IF CRITICAL
   - Urine output, inputs, BW, BP, ECG, RR/lung status, electrolytes
                |
                v
9. REFER EARLY
   - Anuria/oliguria, ureteral obstruction, rising creatinine,
     refractory K/acidosis/overload, dialysis need
                |
                v
10. DISCHARGE ONLY WHEN
    - Stable hydration, controlled vomiting, safe urine output,
      cause addressed, owner can monitor, recheck plan in place

22. MEMORY TOOL

Ten key points

  1. AKI is sudden renal dysfunction, not simply increased creatinine.
  2. Always consider prerenal, intrinsic renal, and postrenal causes.
  3. A normal creatinine does not exclude early AKI.
  4. Urine output is a core vital parameter.
  5. Correct hypovolaemia, but do not force fluids in oliguria/anuria.
  6. Urethral and ureteral obstruction are time-sensitive emergencies.
  7. Hyperkalaemia can kill by arrhythmia.
  8. Cats with suspected lily exposure require immediate action.
  9. Culture urine before antibiotics when practical.
  10. Early referral can change outcome when dialysis or ureteral intervention is needed.

Ten important drug facts

  1. NSAIDs are generally contraindicated in suspected AKI.
  2. Calcium gluconate stabilizes myocardium but does not lower potassium.
  3. Insulin plus dextrose lowers serum potassium temporarily by intracellular shifting.
  4. Furosemide does not cure AKI and should not replace reassessment/referral.
  5. “Renal-dose dopamine” is not a renal-protective treatment.
  6. Maropitant controls vomiting but may not fully control nausea.
  7. Ondansetron is useful for persistent nausea but consider QT risk.
  8. Opioids are preferred analgesics over NSAIDs in AKI.
  9. Avoid aminoglycosides where safer alternatives exist.
  10. Antibiotics require a bacterial indication, culture plan, and renal dosing review.

Ten diagnostic clues

  1. Large painful bladder plus hyperkalaemia: think urethral obstruction.
  2. Small bladder plus azotaemia in a cat: do not miss ureteral obstruction.
  3. Abdominal fluid creatinine/potassium above serum: think uroabdomen.
  4. Fever, renal pain, pyuria: consider pyelonephritis.
  5. AKI plus hepatic/pulmonary signs in a dog: consider leptospirosis.
  6. Severe acidosis with compatible exposure: consider ethylene glycol.
  7. Azotaemia resolving after rehydration: prerenal component likely.
  8. Small irregular kidneys with anaemia: CKD or acute-on-CKD likely.
  9. Rising weight and tachypnoea during fluids: fluid overload until proven otherwise.
  10. Hyperkalaemia plus bradycardia: ECG immediately.

Ten common mistakes

  1. Not measuring urine output.
  2. Giving maintenance fluids automatically to anuric patients.
  3. Missing a postrenal cause.
  4. Delaying ultrasound in a possible ureteral obstruction.
  5. Treating pyuria without culture.
  6. Failing to ask about toxins and medications.
  7. Ignoring blood pressure.
  8. Using nephrotoxic drugs in a high-risk patient.
  9. Waiting too long to discuss dialysis/referral.
  10. Interpreting one lab value rather than serial trends.

Ten high-yield MCQs

  1. In an AKI patient with bradycardia and ECG changes from hyperkalaemia, which treatment stabilizes cardiac membranes?
    Answer: Calcium gluconate.
  2. Does calcium gluconate lower serum potassium?
    Answer: No.
  3. What is the first major diagnostic category to exclude in an azotaemic cat with a small bladder?
    Answer: Ureteral obstruction.
  4. What is the most useful routine measurement for guiding fluids in hospitalized AKI?
    Answer: Accurate urine output plus body weight and input-output balance.
  5. Which drug class is generally avoided in AKI?
    Answer: NSAIDs.
  6. Which sample should ideally be collected before starting antibiotics for suspected pyelonephritis?
    Answer: Urine culture, preferably cystocentesis sample.
  7. Can a patient have early AKI with normal creatinine?
    Answer: Yes.
  8. What is the key treatment for postrenal azotaemia from obstruction?
    Answer: Urgent relief of obstruction.
  9. What is a classic serious toxin exposure causing AKI in cats?
    Answer: Lilies.
  10. What is the fluid goal after deficits have been corrected?
    Answer: Approximately zero fluid balance, matching input to measured/estimated output.

Five clinical pearls

  1. “No urine” is a diagnosis problem before it is a diuretic problem. Confirm catheter patency, obstruction, volume status, BP, and renal perfusion first.
  2. Fluid overload is an iatrogenic emergency. Daily or frequent body weight is often more informative than skin turgor.
  3. Ureteral obstruction can be subtle in cats. A small bladder does not make obstruction unlikely.
  4. Treat the ECG and perfusion, not just numbers. Severe hyperkalaemia can be fatal before a full diagnostic work-up is complete.
  5. Creatinine is delayed and muscle-dependent. Serial trends, USG, urine output, SDMA, and context are stronger than one isolated result.
Recent veterinary literature supports individualized fluid/electrolyte therapy and early use of renal replacement therapy when medical control fails. The recent systematic review of stem-cell approaches in canine/feline renal disease does not justify routine stem-cell therapy for emergency AKI at this stage: 2024 review, PMID 38851051.
This is a shared conversation. Sign in to Orris to start your own chat.